The startup develops a vaginal microbiome testing kit that utilizes machine learning and bioinformatics to analyze microbial compositions linked to recurrent infections and infertility. This technology enables women to gain insights into their microbiome, facilitating personalized health management and improving overall reproductive health.
Funding
$3.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.



EFIAFounders
Product
Problem
Many women experience recurrent vaginal infections and infertility, which can often be linked to imbalances in the vaginal microbiome, yet understanding this complex ecosystem remains challenging. Traditional diagnostic methods often provide incomplete information, leaving women without a clear understanding of their vaginal health.
Solution
Juno Bio offers an at-home vaginal microbiome test that utilizes next-generation sequencing to provide a comprehensive profile of all detectable bacteria and fungi present. This advanced analysis identifies over 10,000 different species and their relative abundance, offering deeper insights compared to traditional PCR tests. Customers receive a detailed report accessible through a private online dashboard, which includes an option to book a consultation with a vaginal health expert to review the results. The test empowers women to proactively manage their vaginal wellness, understand potential causes of recurrent infections or fertility concerns, and make informed decisions about their health.
Target Audience
The primary target audience includes women and individuals with vaginas over the age of 18 who are seeking to understand their vaginal microbiome for wellness purposes, particularly those experiencing recurrent infections, fertility concerns, or (peri)menopause symptoms.
Features
- At-home vaginal swab collection for easy and convenient sample acquisition
- Next-generation sequencing (NGS) technology for comprehensive detection of all bacteria and fungi present
- Identification of over 10,000 microbial species with 0.1% resolution
- Detailed report including relative abundance of each detected species
- Online dashboard for secure access to test results and personalized insights
- Option to book a one-on-one consultation with a vaginal health expert
- Ability to use HSA/FSA funds for test purchase
- International shipping available